Sign inJoin waitlistJoin the waitlist

Jeremy Brownstein

Physician · Arthur G James Cancer Hospital and Research Institute

Credentials: · · · ·

History

Arthur G James Cancer Hospital and Research Institute
2020–Present

Radiation Oncology
Duke University Hospital
2014–2018
Preliminary or Transitional Year
2013–2014
State University of New York at Stony Brook Hlth Science Cntr School of Medicine
2009–2013

Research

Method and Atlas to Enable Targeting for Cardiac Radioablation Employing the American Heart Association Segmented Model
International journal of radiation oncology · 2021 · First of 10 authors · 29 citations
Brachytherapy via a depot of biopolymer-bound 131I synergizes with nanoparticle paclitaxel in therapy-resistant pancreatic tumours
Nature Biomedical Engineering · 2022 · 29 citations
Association Between Pretreatment Chest Imaging and Immune Checkpoint Inhibitor Pneumonitis Among Patients With Lung Cancer
Journal of the National Comprehensive Cancer Network · 2023 · 26 citations

TW
Terence Williams
7 papers
David Kirsch
5 papers
Karl Haglund
5 papers
David Carbone
4 papers
KH
Kai He
4 papers
Carolyn Presley
3 papers
Dwight Owen
3 papers
GO
Gregory Otterson
3 papers
Joshua Palmer
3 papers
Matthew Tong
3 papers · 2 as a fellow
Muhammad Afzal
3 papers
Peter Shields
3 papers

Clinical trials

Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases
Principal investigator · Active not recruiting · Phase 1
Ohio State University Comprehensive Cancer Center
2019–2027
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Study chair · Recruiting · Phase 2
Alliance for Clinical Trials in Oncology
2026–2032
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
Site PI · Recruiting
Varian, a Siemens Healthineers Company
2023–2030
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer
Site PI · Recruiting · Phase 1
Ohio State University Comprehensive Cancer Center
2021–2026